SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
SK Biopharmaceuticals,Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates usingan alpha-particleemittingradioisotope,acti